We are live on ! Find out more
LVACU

LAVA Medtech Acquisition Corp. Unit
LVACU

Delisted

LVACU was delisted on the 19th of April, 2023.

Back to rankings

17 hedge funds and large institutions have $19.6M invested in LAVA Medtech Acquisition Corp. Unit in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 9 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% less funds holding

Funds holding: 39 → 17 (-22)

71% less capital invested

Capital invested by funds: $66.5M → $19.6M (-$46.9M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 22

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 9

Holders
17
Holders Change
-22
Holders Change %
-56.41%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
9
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
SCM
Shaolin Capital Management
Florida
-$5.04M
2
GL
Governors Lane
New York
-$5.04M
3
PC
Periscope Capital
Ontario, Canada
-$4.13M
4
PMAM
Picton Mahoney Asset Management
Ontario, Canada
-$3.85M
5
UOC
UBS O'Connor
Illinois
-$3.24M

LVACU Hedge Fund Activity: Q1 2022 in Review

17 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Unit (LVACU) for Q1 2022, worth a combined $19.6M — down 71% from $66.5M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of LVACU and 0 opened new positions — a net loss of 22 holders — while 9 trimmed existing stakes and 0 added.

The largest seller was Shaolin Capital Management, exiting entirely with an estimated $5.04M sold.

  • 17 institutional investors held LAVA Medtech Acquisition Corp. Unit (LVACU) as of Q1 2022, down from 39 in Q4 2021.
  • Funds reported $19.6M of LAVA Medtech Acquisition Corp. Unit stock for Q1 2022, down 71% quarter-over-quarter.
  • 0 funds opened new LAVA Medtech Acquisition Corp. Unit positions in Q1 2022 and 22 closed out, a net change of -22 holders.
  • The largest LAVA Medtech Acquisition Corp. Unit seller in Q1 2022 was Shaolin Capital Management, an estimated $5.04M sold.

Based on aggregated 13F filings for Q1 2022.